Oncolytics Biotech Inc. (NASDAQ:ONCY) People

Oncolytics Biotech Inc.

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Patricia S Andrews
Other companies: Geron Corporation (Director · Since at least Mar 25, 2026); Crescent Biopharma, Inc. (Director · Jun 9, 2017 – May 1, 2024 · Past); Incyte Corporation (Chief Commercial Officer · Oct 21, 2008 – Jan 19, 2012 · Past)
Director · Since at least Jan 1, 2026
Bernd R. Seizinger
Other companies: Aprea Therapeutics, Inc. (Director · Since at least Oct 2, 2019); Aptose Biosciences Inc (Director · Sep 13, 2022 – Feb 5, 2024 · Past)
Director · Since at least Jan 1, 2026
James Parsons
Other companies: DiaMedica Therapeutics Inc. (Chairman of the Board · Since at least Dec 6, 2018); Trillium Therapeutics Inc (Chief Financial Officer · Jan 1, 2021 – Nov 17, 2021 · Past)
Director · Since at least Jan 1, 2026
Jonathan Rigby
Other companies: BioPlus Acquisition Corp (Chief Business Officer, Director · Dec 2, 2021 – Dec 2, 2021 · Past); SteadyMed Ltd (President and CEO, Director · Dec 28, 2017 – Aug 30, 2018 · Past)
Director · Since at least Jan 1, 2026
Wayne Pisano
Other companies: Altimmune, Inc. (Director · Since at least Aug 30, 2018); Provention Bio Inc (Director · Jul 3, 2018 – Apr 27, 2023 · Past)
Director · Since at least Jun 26, 2025
Andrew Aromando
Other companies: Ambrx Biopharma Inc. (Chief Operating Officer · Apr 28, 2023 – Mar 7, 2024 · Past)
Chief Business Officer · Since at least Jun 30, 2025
John McAdory
Other companies: CG Oncology, Inc. (EVP of Strategy and Operations · Jan 14, 2026 – Nov 5, 2026 · Past)
Chief Operating Officer · Since at least Jun 1, 2026
Allison HagermanChief Technology Officer · Since at least Nov 5, 2026
Allison HagermanChief Technology Officer · Since at least Jan 1, 2026
Angela HolthamDirector · Since at least Jan 1, 2026
Angela HolthamDirector · Since at least Nov 4, 2026
Deborah M. BrownDirector · Since at least Jan 1, 2026
Jared KellyChief Executive Officer & Director · Since at least Jan 1, 2026
Jon PattonDirector of Investor Relations & Communication · Since at least Oct 27, 2026
Kirk LookChief Financial Officer · Since at least Nov 5, 2026
Pat AndrewsDirector · Since at least Nov 5, 2026
Steve GloverDirector · Since at least Jun 2, 2026
Thomas C. HeinemanChief Medical Officer · Since at least Jan 1, 2026